Biologics News

Bacterin International Holdings recently announced the launch of two new demineralized bone matrix constructs for spinal procedures.

Orthopedics Today has put together a compilation of the five news stories and videos most viewed from October 2014 to keep you abreast of the current hot topics in orthopedics.

Aesculap Biologics recently announced that the first clinical study patient was implanted with the company’s Novocart 3-D product.

In the first part of this Orthopedics TodayRound Table on the use of biologic augmentation in soft tissue healing, our panel discussed the current status and future potential of platelet-rich plasma. We also discussed current issues related to stem cells, and the limitations imposed by the current regulatory environment. In this continuation of our discussion, I have asked the panelists to address further questions that directly relate to the potential clinical use of stem cells. The panelists discuss the possibility of using various “off-the-shelf” allogeneic cell sources. The panelists also provide their thoughts about combining stem cells with scaffolds to augment tissue repair. I then finish with some concluding remarks related to biologic augmentation of soft tissue healing.

An active 68-year-old right-handed woman with inflammatory arthritis, presented to clinic with right shoulder pain. She denied any antecedent trauma and noted progressive right shoulder pain during the past 6 years. Over the previous years, she had been managed with physical therapy and activity modification. She received two separate corticosteroid injections into the right glenohumeral joint, with the latter providing only short-term relief.

Orthopedics Today has highlighted six important videos to keep your practice up-to-date on a multitude of topics in orthopedic medicine.

In recent years, there has been increasing interest in strategies to augment the biology of soft tissue healing.

Wright Medical Group has announced that its board of directors and that of Tornier N.V. have unanimously approved a merger agreement between the companies to form Wright Medical Group N.V.

Utrecht University and University Medical Center Utrecht announced they will begin offering a 2-year biofabrication research master’s program beginning September 2015.

Sequential reaming of the intramedullary femoral bone canal may produce substantial amounts of bone graft on multiple occasions, according to recently published data.